Outcome of mitral valve repair in patients with preoperative atrial fibrillation: Should the maze procedure be combined with mitral valvuloplasty?

Y. L. Chua, Hartzell V Schaff, T. A. Orszulak, J. J. Morris, Y. Kawashima, L. I. Bonchek, J. L. Cox

Research output: Contribution to journalArticle

196 Citations (Scopus)

Abstract

To examine late outcome of mitral valve repair in patients with preoperative atrial fibrillation, we reviewed the cases of 323 consecutive patients who underwent mitral valvuloplasty for mitral regurgitation from 1980 to 1991; average age of 215 men and 108 women was 64 years (range 14 to 88 years), and 224 patients (70%) were in New York Heart Association class III or IV before operation. The main indications for operation were severe mitral regurgitation (76%), coronary artery disease with associated mitral regurgitation (15%), and aortic valve disease (6%). At the time of mitral valve repair, coronary artery bypass grafting was done in 35% of patients, aortic valve replacement was done in 7%, and multiple other procedures were done in 10%. For all patients, the 30-day mortality rate was 2.5% (70% confidence limits 1.6% to 3.4%) and survivorships at 3 and 5 years were 81% and 76%, respectively. Before operation, 216 patients were in sinus rhythm and 97 patients had atrial fibrillation; in the latter group, 11 had recent onset of atrial fibrillation within 3 months preceding mitral valve repair. Comparing patients with preoperative atrial fibrillation to those with sinus rhythm, we found no significant difference in operative mortality (3% versus 1.9%) or 5-year survivorship (74.3% ± 6.3% versus 76.9% ± 4.0%). At late follow-up, atrial fibrillation was present in 5% of patients with preoperative sinus rhythm, 80% of patients with preoperative chronic atrial fibrillation, and 0% of patients with preoperative recent onset atrial fibrillation (p < 0.01). The left atrial size by echocardiography was larger in patients with preoperative atrial fibrillation compared with that in those with sinus rhythm (59 ± 1.4 mm versus 50.9 ± 0.7 mm; p < 0.05). There was, however, only a weak correlation between preoperative left atrial size and late atrial fibrillation. Further, age, gender, and associated coronary artery disease did not correlate with presence of atrial fibrillation at late follow-up. Prevalence of late thromboembolic events was similar in patients with preoperative sinus rhythm compared with that in those with atrial fibrillation. These data suggest that mitral valve repair should be done before or soon after the onset of atrial fibrillation to maximize the chance of postoperative sinus rhythm and avoid long-term anticoagulation with warfarin. However, the early and late results of mitral valve repair in patients with chronic atrial fibrillation are good, and concomitant operation for supraventricular arrhythmia must have negligible morbidity and no adverse effect on operative mortality.

Original languageEnglish (US)
Pages (from-to)408-415
Number of pages8
JournalJournal of Thoracic and Cardiovascular Surgery
Volume107
Issue number2
StatePublished - 1994

Fingerprint

Mitral Valve
Atrial Fibrillation
Mitral Valve Insufficiency
Aortic Valve
Mortality
Coronary Artery Disease
Survival Rate
Aortic Diseases
Warfarin
Coronary Artery Bypass
Echocardiography
Cardiac Arrhythmias

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Outcome of mitral valve repair in patients with preoperative atrial fibrillation : Should the maze procedure be combined with mitral valvuloplasty? / Chua, Y. L.; Schaff, Hartzell V; Orszulak, T. A.; Morris, J. J.; Kawashima, Y.; Bonchek, L. I.; Cox, J. L.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 107, No. 2, 1994, p. 408-415.

Research output: Contribution to journalArticle

@article{4dd147cf3701463c8a28c1d2a75f1d42,
title = "Outcome of mitral valve repair in patients with preoperative atrial fibrillation: Should the maze procedure be combined with mitral valvuloplasty?",
abstract = "To examine late outcome of mitral valve repair in patients with preoperative atrial fibrillation, we reviewed the cases of 323 consecutive patients who underwent mitral valvuloplasty for mitral regurgitation from 1980 to 1991; average age of 215 men and 108 women was 64 years (range 14 to 88 years), and 224 patients (70{\%}) were in New York Heart Association class III or IV before operation. The main indications for operation were severe mitral regurgitation (76{\%}), coronary artery disease with associated mitral regurgitation (15{\%}), and aortic valve disease (6{\%}). At the time of mitral valve repair, coronary artery bypass grafting was done in 35{\%} of patients, aortic valve replacement was done in 7{\%}, and multiple other procedures were done in 10{\%}. For all patients, the 30-day mortality rate was 2.5{\%} (70{\%} confidence limits 1.6{\%} to 3.4{\%}) and survivorships at 3 and 5 years were 81{\%} and 76{\%}, respectively. Before operation, 216 patients were in sinus rhythm and 97 patients had atrial fibrillation; in the latter group, 11 had recent onset of atrial fibrillation within 3 months preceding mitral valve repair. Comparing patients with preoperative atrial fibrillation to those with sinus rhythm, we found no significant difference in operative mortality (3{\%} versus 1.9{\%}) or 5-year survivorship (74.3{\%} ± 6.3{\%} versus 76.9{\%} ± 4.0{\%}). At late follow-up, atrial fibrillation was present in 5{\%} of patients with preoperative sinus rhythm, 80{\%} of patients with preoperative chronic atrial fibrillation, and 0{\%} of patients with preoperative recent onset atrial fibrillation (p < 0.01). The left atrial size by echocardiography was larger in patients with preoperative atrial fibrillation compared with that in those with sinus rhythm (59 ± 1.4 mm versus 50.9 ± 0.7 mm; p < 0.05). There was, however, only a weak correlation between preoperative left atrial size and late atrial fibrillation. Further, age, gender, and associated coronary artery disease did not correlate with presence of atrial fibrillation at late follow-up. Prevalence of late thromboembolic events was similar in patients with preoperative sinus rhythm compared with that in those with atrial fibrillation. These data suggest that mitral valve repair should be done before or soon after the onset of atrial fibrillation to maximize the chance of postoperative sinus rhythm and avoid long-term anticoagulation with warfarin. However, the early and late results of mitral valve repair in patients with chronic atrial fibrillation are good, and concomitant operation for supraventricular arrhythmia must have negligible morbidity and no adverse effect on operative mortality.",
author = "Chua, {Y. L.} and Schaff, {Hartzell V} and Orszulak, {T. A.} and Morris, {J. J.} and Y. Kawashima and Bonchek, {L. I.} and Cox, {J. L.}",
year = "1994",
language = "English (US)",
volume = "107",
pages = "408--415",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Outcome of mitral valve repair in patients with preoperative atrial fibrillation

T2 - Should the maze procedure be combined with mitral valvuloplasty?

AU - Chua, Y. L.

AU - Schaff, Hartzell V

AU - Orszulak, T. A.

AU - Morris, J. J.

AU - Kawashima, Y.

AU - Bonchek, L. I.

AU - Cox, J. L.

PY - 1994

Y1 - 1994

N2 - To examine late outcome of mitral valve repair in patients with preoperative atrial fibrillation, we reviewed the cases of 323 consecutive patients who underwent mitral valvuloplasty for mitral regurgitation from 1980 to 1991; average age of 215 men and 108 women was 64 years (range 14 to 88 years), and 224 patients (70%) were in New York Heart Association class III or IV before operation. The main indications for operation were severe mitral regurgitation (76%), coronary artery disease with associated mitral regurgitation (15%), and aortic valve disease (6%). At the time of mitral valve repair, coronary artery bypass grafting was done in 35% of patients, aortic valve replacement was done in 7%, and multiple other procedures were done in 10%. For all patients, the 30-day mortality rate was 2.5% (70% confidence limits 1.6% to 3.4%) and survivorships at 3 and 5 years were 81% and 76%, respectively. Before operation, 216 patients were in sinus rhythm and 97 patients had atrial fibrillation; in the latter group, 11 had recent onset of atrial fibrillation within 3 months preceding mitral valve repair. Comparing patients with preoperative atrial fibrillation to those with sinus rhythm, we found no significant difference in operative mortality (3% versus 1.9%) or 5-year survivorship (74.3% ± 6.3% versus 76.9% ± 4.0%). At late follow-up, atrial fibrillation was present in 5% of patients with preoperative sinus rhythm, 80% of patients with preoperative chronic atrial fibrillation, and 0% of patients with preoperative recent onset atrial fibrillation (p < 0.01). The left atrial size by echocardiography was larger in patients with preoperative atrial fibrillation compared with that in those with sinus rhythm (59 ± 1.4 mm versus 50.9 ± 0.7 mm; p < 0.05). There was, however, only a weak correlation between preoperative left atrial size and late atrial fibrillation. Further, age, gender, and associated coronary artery disease did not correlate with presence of atrial fibrillation at late follow-up. Prevalence of late thromboembolic events was similar in patients with preoperative sinus rhythm compared with that in those with atrial fibrillation. These data suggest that mitral valve repair should be done before or soon after the onset of atrial fibrillation to maximize the chance of postoperative sinus rhythm and avoid long-term anticoagulation with warfarin. However, the early and late results of mitral valve repair in patients with chronic atrial fibrillation are good, and concomitant operation for supraventricular arrhythmia must have negligible morbidity and no adverse effect on operative mortality.

AB - To examine late outcome of mitral valve repair in patients with preoperative atrial fibrillation, we reviewed the cases of 323 consecutive patients who underwent mitral valvuloplasty for mitral regurgitation from 1980 to 1991; average age of 215 men and 108 women was 64 years (range 14 to 88 years), and 224 patients (70%) were in New York Heart Association class III or IV before operation. The main indications for operation were severe mitral regurgitation (76%), coronary artery disease with associated mitral regurgitation (15%), and aortic valve disease (6%). At the time of mitral valve repair, coronary artery bypass grafting was done in 35% of patients, aortic valve replacement was done in 7%, and multiple other procedures were done in 10%. For all patients, the 30-day mortality rate was 2.5% (70% confidence limits 1.6% to 3.4%) and survivorships at 3 and 5 years were 81% and 76%, respectively. Before operation, 216 patients were in sinus rhythm and 97 patients had atrial fibrillation; in the latter group, 11 had recent onset of atrial fibrillation within 3 months preceding mitral valve repair. Comparing patients with preoperative atrial fibrillation to those with sinus rhythm, we found no significant difference in operative mortality (3% versus 1.9%) or 5-year survivorship (74.3% ± 6.3% versus 76.9% ± 4.0%). At late follow-up, atrial fibrillation was present in 5% of patients with preoperative sinus rhythm, 80% of patients with preoperative chronic atrial fibrillation, and 0% of patients with preoperative recent onset atrial fibrillation (p < 0.01). The left atrial size by echocardiography was larger in patients with preoperative atrial fibrillation compared with that in those with sinus rhythm (59 ± 1.4 mm versus 50.9 ± 0.7 mm; p < 0.05). There was, however, only a weak correlation between preoperative left atrial size and late atrial fibrillation. Further, age, gender, and associated coronary artery disease did not correlate with presence of atrial fibrillation at late follow-up. Prevalence of late thromboembolic events was similar in patients with preoperative sinus rhythm compared with that in those with atrial fibrillation. These data suggest that mitral valve repair should be done before or soon after the onset of atrial fibrillation to maximize the chance of postoperative sinus rhythm and avoid long-term anticoagulation with warfarin. However, the early and late results of mitral valve repair in patients with chronic atrial fibrillation are good, and concomitant operation for supraventricular arrhythmia must have negligible morbidity and no adverse effect on operative mortality.

UR - http://www.scopus.com/inward/record.url?scp=0028314139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028314139&partnerID=8YFLogxK

M3 - Article

C2 - 8302059

AN - SCOPUS:0028314139

VL - 107

SP - 408

EP - 415

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 2

ER -